COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $325,784 | -2.4% | 87,108 | +9.4% | 0.00% | – |
| Q2 2023 | $333,646 | +193880.2% | 79,629 | +197.1% | 0.00% | – |
| Q1 2023 | $172 | -55.9% | 26,800 | -45.5% | 0.00% | – |
| Q4 2022 | $390 | -99.8% | 49,199 | +284.4% | 0.00% | – |
| Q4 2021 | $214,000 | -34.4% | 12,800 | -44.8% | 0.00% | – |
| Q2 2021 | $326,000 | +100.0% | 23,200 | +105.3% | 0.00% | – |
| Q1 2021 | $163,000 | -58.5% | 11,300 | -45.9% | 0.00% | -100.0% |
| Q3 2020 | $393,000 | -55.1% | 20,900 | -58.1% | 0.00% | -50.0% |
| Q4 2019 | $876,000 | +862.6% | 49,912 | +389.3% | 0.00% | – |
| Q4 2018 | $91,000 | -52.4% | 10,200 | -12.1% | 0.00% | – |
| Q3 2018 | $191,000 | +67.5% | 11,600 | -10.1% | 0.00% | – |
| Q4 2017 | $114,000 | -80.8% | 12,900 | -71.0% | 0.00% | -100.0% |
| Q3 2017 | $595,000 | -50.8% | 44,532 | -46.8% | 0.00% | -50.0% |
| Q2 2017 | $1,209,000 | +381.7% | 83,675 | +840.2% | 0.01% | +500.0% |
| Q4 2016 | $251,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |